Arcturus Therapeutics Holdings Inc. SEC filings ARCT

Arcturus Therapeutics Holdings Inc. has 416 filings in SEC EDGAR's recent list, going back to Mar 18, 2019. Its latest annual report, Form 10-K, was filed on Mar 3, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

Arcturus Therapeutics Holdings Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 5, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 5, 2026 Nov 5, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 29, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 7, 2026 —
8-K Current report
Regulation FD disclosure
Sep 23, 2026 Sep 23, 2026
8-K Current report
Regulation FD disclosure
Aug 25, 2026 Aug 25, 2026
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
8-K Current report
Material agreement, Regulation FD disclosure
Jul 2, 2026 Jun 26, 2026
4 Insider transaction Jun 15, 2026 Jun 5, 2026
4 Insider transaction Jun 15, 2026 Jun 5, 2026
4 Insider transaction Jun 15, 2026 Jun 5, 2026
4 Insider transaction Jun 15, 2026 Jun 5, 2026
4 Insider transaction Jun 15, 2026 Jun 5, 2026
4 Insider transaction Jun 15, 2026 Jun 5, 2026
4 Insider transaction Jun 15, 2026 Jun 5, 2026
8-K Current report
Shareholder vote results
Jun 5, 2026 Jun 5, 2026
4 Insider transaction May 7, 2026 May 1, 2026
3 Initial insider ownership May 7, 2026 May 1, 2026
10-Q Quarterly report May 7, 2026 Mar 31, 2026
8-K Current report
Results of operations, Officer or director change, Regulation FD disclosure
May 7, 2026 May 1, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 7, 2026 —
DEF 14A Proxy statement Apr 24, 2026 Jun 5, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 26, 2026 —
10-K Annual report Mar 3, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 3, 2026 Mar 3, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 3, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 8, 2026 —
S-3 Shelf registration Dec 30, 2025 —
4 Insider transaction Dec 19, 2025 Dec 17, 2025
4 Insider transaction Dec 19, 2025 Dec 17, 2025
4 Insider transaction Dec 19, 2025 Dec 17, 2025
4 Insider transaction Dec 19, 2025 Dec 17, 2025
3 Initial insider ownership Dec 19, 2025 Dec 12, 2025
8-K Current report
Officer or director change
Dec 15, 2025 Dec 11, 2025
SCHEDULE 13G Ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 13, 2025 —
10-Q Quarterly report Nov 12, 2025 Sep 30, 2025
NT 10-Q Filing Nov 12, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 10, 2025 Nov 10, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 27, 2025 —
8-K Current report
Regulation FD disclosure, Other events
Oct 22, 2025 Oct 22, 2025
8-K Current report
Regulation FD disclosure
Sep 26, 2025 Sep 26, 2025
8-K Current report
Regulation FD disclosure
Aug 29, 2025 Aug 29, 2025
4/A Filing Aug 20, 2025 Aug 15, 2025
4 Insider transaction Aug 19, 2025 Aug 15, 2025
10-Q Quarterly report Aug 11, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 11, 2025 Aug 11, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 30, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 29, 2025 —
8-K Current report
Regulation FD disclosure
Jun 30, 2025 Jun 30, 2025
4 Insider transaction Jun 11, 2025 Jun 9, 2025
4 Insider transaction Jun 11, 2025 Jun 9, 2025
4 Insider transaction Jun 11, 2025 Jun 9, 2025
4 Insider transaction Jun 11, 2025 Jun 9, 2025
4 Insider transaction Jun 11, 2025 Jun 9, 2025
4 Insider transaction Jun 11, 2025 Jun 9, 2025
4 Insider transaction Jun 11, 2025 Jun 9, 2025
8-K Current report
Shareholder vote results
Jun 6, 2025 Jun 6, 2025
10-Q Quarterly report May 12, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 12, 2025 May 12, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 12, 2025 —
DEF 14A Proxy statement Apr 25, 2025 Jun 6, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 25, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 23, 2025 —
10-K Annual report Mar 6, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 6, 2025 Mar 6, 2025
SCHEDULE 13G Ownership over 5% (passive) Feb 5, 2025 —
4 Insider transaction Dec 18, 2024 Dec 16, 2024
4 Insider transaction Dec 18, 2024 Dec 16, 2024
4 Insider transaction Dec 18, 2024 Dec 16, 2024
4 Insider transaction Dec 18, 2024 Dec 16, 2024
SC 13G Ownership over 5% (passive) Nov 8, 2024 —
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 7, 2024 Nov 7, 2024
SC 13G Ownership over 5% (passive) Nov 5, 2024 —
4 Insider transaction Oct 16, 2024 Oct 15, 2024
144 Notice of proposed sale Oct 15, 2024 —
8-K Current report
Regulation FD disclosure
Aug 13, 2024 Aug 13, 2024
10-Q Quarterly report Aug 5, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 5, 2024 Aug 5, 2024
S-8 Employee stock plan registration Jul 17, 2024 —
8-K Current report
Officer or director change, Regulation FD disclosure
Jun 24, 2024 Jun 19, 2024
4 Insider transaction Jun 21, 2024 Jun 19, 2024
3 Initial insider ownership Jun 21, 2024 Jun 19, 2024
4 Insider transaction Jun 18, 2024 Jun 14, 2024
4 Insider transaction Jun 18, 2024 Jun 14, 2024
4 Insider transaction Jun 18, 2024 Jun 14, 2024
4 Insider transaction Jun 18, 2024 Jun 14, 2024
4 Insider transaction Jun 18, 2024 Jun 14, 2024
4 Insider transaction Jun 18, 2024 Jun 14, 2024
144 Notice of proposed sale Jun 18, 2024 —
8-K Current report
Officer or director change, Shareholder vote results
Jun 14, 2024 Jun 14, 2024
4 Insider transaction Jun 14, 2024 Jun 12, 2024
144 Notice of proposed sale Jun 12, 2024 —
4 Insider transaction Jun 7, 2024 Jun 5, 2024
144 Notice of proposed sale Jun 5, 2024 —
4 Insider transaction Jun 4, 2024 Jun 3, 2024
144 Notice of proposed sale Jun 3, 2024 —
10-Q Quarterly report May 8, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 8, 2024 May 8, 2024
DEF 14A Proxy statement Apr 29, 2024 Jun 14, 2024
8-K Current report
Auditor change
Apr 5, 2024 Apr 5, 2024
SC 13G/A Amended ownership over 5% (passive) Apr 5, 2024 —
4 Insider transaction Mar 27, 2024 Mar 25, 2024
4 Insider transaction Mar 21, 2024 Mar 19, 2024
144 Notice of proposed sale Mar 19, 2024 —
8-K Current report
Regulation FD disclosure
Mar 19, 2024 Mar 19, 2024
10-K Annual report Mar 14, 2024 Dec 31, 2023
8-K/A Amended current report
Results of operations
Mar 14, 2024 Mar 7, 2024
8-K Current report
Results of operations
Mar 7, 2024 Mar 7, 2024
8-K Current report
Officer or director change
Feb 23, 2024 Feb 20, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 12, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 5, 2024 —
SC 13G/A Amended ownership over 5% (passive) Jan 29, 2024 —
SC 13G/A Amended ownership over 5% (passive) Jan 25, 2024 —
SC 13G/A Amended ownership over 5% (passive) Jan 25, 2024 —
SC 13G/A Amended ownership over 5% (passive) Jan 17, 2024 —
4 Insider transaction Dec 19, 2023 Dec 15, 2023
4 Insider transaction Dec 19, 2023 Dec 15, 2023
4 Insider transaction Dec 19, 2023 Dec 15, 2023
4 Insider transaction Dec 19, 2023 Dec 15, 2023
4 Insider transaction Dec 19, 2023 Dec 15, 2023
10-Q Quarterly report Nov 14, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 14, 2023 Nov 14, 2023
4 Insider transaction Nov 3, 2023 Nov 1, 2023
SC 13G/A Amended ownership over 5% (passive) Oct 10, 2023 —
4 Insider transaction Oct 4, 2023 Oct 2, 2023
144 Notice of proposed sale Oct 2, 2023 —
8-K Current report
Material agreement, Other events
Sep 26, 2023 Sep 25, 2023
4 Insider transaction Sep 5, 2023 Sep 1, 2023
144 Notice of proposed sale Sep 1, 2023 —
4 Insider transaction Aug 17, 2023 Aug 15, 2023
8-K Current report
Material agreement, Other events
Aug 14, 2023 Aug 10, 2023
10-Q Quarterly report Aug 7, 2023 Jun 30, 2023
8-K Current report
Results of operations, Other events
Aug 7, 2023 Aug 7, 2023
424B5 Prospectus supplement Aug 7, 2023 —
4 Insider transaction Aug 3, 2023 Aug 1, 2023
4 Insider transaction Aug 3, 2023 Aug 1, 2023
4 Insider transaction Aug 3, 2023 Aug 1, 2023
4 Insider transaction Aug 3, 2023 Aug 1, 2023
4 Insider transaction Aug 3, 2023 Aug 1, 2023
4 Insider transaction Aug 3, 2023 Aug 1, 2023
4 Insider transaction Aug 3, 2023 Aug 1, 2023
144 Notice of proposed sale Aug 1, 2023 —
4 Insider transaction Jul 18, 2023 Jul 14, 2023
4 Insider transaction Jul 18, 2023 Jul 14, 2023
144 Notice of proposed sale Jul 14, 2023 —
144 Notice of proposed sale Jul 14, 2023 —
8-K Current report
Regulation FD disclosure
Jul 14, 2023 Jul 13, 2023
4 Insider transaction Jul 7, 2023 Jul 3, 2023
8-K Current report
Regulation FD disclosure
Jun 30, 2023 Jun 30, 2023
8-K Current report
Shareholder vote results
Jun 16, 2023 Jun 14, 2023
4 Insider transaction Jun 5, 2023 Jun 1, 2023
4 Insider transaction May 12, 2023 May 10, 2023
144 Notice of proposed sale May 11, 2023 —
144 Notice of proposed sale May 10, 2023 —
10-Q Quarterly report May 9, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 9, 2023 May 9, 2023
4 Insider transaction May 3, 2023 May 1, 2023
DEF 14A Proxy statement May 1, 2023 Jun 14, 2023
8-K Current report
Regulation FD disclosure
Apr 28, 2023 Apr 28, 2023
8-K Current report
Material agreement, New debt
Apr 21, 2023 Apr 21, 2023
4 Insider transaction Apr 19, 2023 Apr 17, 2023
144 Notice of proposed sale Apr 17, 2023 —
8-K Current report
Regulation FD disclosure
Apr 11, 2023 Apr 11, 2023
4 Insider transaction Apr 5, 2023 Apr 3, 2023
10-K Annual report Mar 29, 2023 Dec 31, 2022
8-K Current report
Results of operations
Mar 28, 2023 Mar 28, 2023
8-K Current report
Agreement ended
Mar 17, 2023 Mar 14, 2023
4 Insider transaction Mar 8, 2023 Mar 6, 2023
SC 13G/A Amended ownership over 5% (passive) Feb 10, 2023 —
SC 13G/A Amended ownership over 5% (passive) Feb 10, 2023 —
SC 13G Ownership over 5% (passive) Feb 9, 2023 —
SC 13G/A Amended ownership over 5% (passive) Feb 8, 2023 —
SC 13G/A Amended ownership over 5% (passive) Feb 3, 2023 —
SC 13G/A Amended ownership over 5% (passive) Feb 1, 2023 —
SC 13G/A Amended ownership over 5% (passive) Jan 31, 2023 —
EFFECT Filing Dec 30, 2022 —
CORRESP Letter to the SEC Dec 30, 2022 —
UPLOAD Letter from the SEC Dec 29, 2022 —
DEL AM Filing Dec 27, 2022 —
S-3 Shelf registration Dec 23, 2022 —
4 Insider transaction Dec 19, 2022 Dec 15, 2022
4 Insider transaction Dec 16, 2022 Dec 9, 2022
8-K Current report
Officer or director change, Regulation FD disclosure
Dec 13, 2022 Dec 8, 2022
4 Insider transaction Dec 13, 2022 Dec 8, 2022
3 Initial insider ownership Dec 13, 2022 Dec 8, 2022
4 Insider transaction Dec 13, 2022 Dec 9, 2022
4 Insider transaction Dec 13, 2022 Dec 9, 2022
4 Insider transaction Dec 13, 2022 Dec 9, 2022
4 Insider transaction Dec 13, 2022 Dec 9, 2022
8-K Current report
Regulation FD disclosure
Dec 13, 2022 Dec 8, 2022
4 Insider transaction Nov 28, 2022 Nov 23, 2022
10-Q Quarterly report Nov 9, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 9, 2022 Nov 9, 2022
8-K Current report
Material agreement, Agreement ended
Nov 4, 2022 Oct 31, 2022
8-K Current report
Material agreement
Nov 2, 2022 Nov 1, 2022

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ARCT (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
San Diego, CA
SEC filer status
Accelerated filer, Smaller reporting company
SEC CIK
1768224

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.